• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $FLACU

    Frazier Lifesciences Acquisition Corporation

    Subscribe to $FLACU
    $FLACU

    Frazier Lifesciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses or entities in the biotechnology sector. The company was incorporated in 2020 and is based in Seattle, Washington.

    IPO Year: 2020

    Exchange: NASDAQ

    Website: frazierlifesciencesacquisition.com

    Recent Analyst Ratings for Frazier Lifesciences Acquisition Corporation

    DatePrice TargetRatingAnalyst
    See more ratings

    Frazier Lifesciences Acquisition Corporation SEC Filings

    View All

    SEC Form 8-K filed

    8-K - Frazier Lifesciences Acquisition Corp (0001828326) (Filer)

    1/29/21 4:05:51 PM ET
    $FLACU

    SEC Form SC 13D filed

    SC 13D - Frazier Lifesciences Acquisition Corp (0001828326) (Subject)

    1/27/21 4:48:28 PM ET
    $FLACU